BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10785559)

  • 1. Substituted 1,2,3-triazolo[1,5-a]quinazolines: synthesis and binding to benzodiazepine and adenosine receptors.
    Bertelli L; Biagi G; Giorgi I; Livi O; Manera C; Scartoni V; Lucacchini A; Giannaccini G; Barili PL
    Eur J Med Chem; 2000 Mar; 35(3):333-41. PubMed ID: 10785559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New 1,2,3-triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors. II.
    Biagi G; Giorgi I; Livi O; Scartoni V; Betti L; Giannaccini G; Trincavelli ML
    Eur J Med Chem; 2002 Jul; 37(7):565-71. PubMed ID: 12126775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonists.
    Francis JE; Cash WD; Psychoyos S; Ghai G; Wenk P; Friedmann RC; Atkins C; Warren V; Furness P; Hyun JL
    J Med Chem; 1988 May; 31(5):1014-20. PubMed ID: 3361572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,2,3-triazolo[1.5-a]quinazolines: synthesis, benzodiazepine receptor binding and theoretical calculations.
    Biagi G; Giorgi I; Livi O; Scartoni V; Velo S; Lucacchini A; Senatore G; De Santis B; Martinelli A
    Farmaco; 1996 Feb; 51(2):131-6. PubMed ID: 8857209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 3-aralkyl-7-(amino-substituted)-1,2,3-triazolo[4,5-d]pyrimidines with high affinity toward A1 adenosine receptors.
    Betti L; Biagi G; Giannaccini G; Giorgi I; Livi O; Lucacchini A; Manera C; Scartoni V
    J Med Chem; 1998 Feb; 41(5):668-73. PubMed ID: 9513594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and benzodiazepine binding activity of a series of novel [1,2,4]triazolo[1,5-c]quinazolin-5(6H)-ones.
    Francis JE; Cash WD; Barbaz BS; Bernard PS; Lovell RA; Mazzenga GC; Friedmann RC; Hyun JL; Braunwalder AF; Loo PS
    J Med Chem; 1991 Jan; 34(1):281-90. PubMed ID: 1846920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2,4-Triazolo[1,5-a]quinoxaline derivatives: synthesis and biological evaluation as adenosine receptor antagonists.
    Catarzi D; Colotta V; Varano F; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
    Farmaco; 2004 Feb; 59(2):71-81. PubMed ID: 14871498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and preliminary use of 1-, 2- and 3-methyl-5-phenyl-7-chloro-1,2,3-triazolo[4,5-d]pyrimidine as reaction intermediates.
    Biagi G; Giorgi I; Livi O; Scartoni V; Barili PL
    Farmaco; 2003 Aug; 58(8):551-6. PubMed ID: 12875884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-substituted 4-[chloropyrazolyl][1,2,4]triazolo[4,3-a]quinoxalines: synthesis and structure-activity relationships of a new class of benzodiazepine and adenosine receptor ligands.
    Matuszczak B; Pekala E; Müller CE
    Arch Pharm (Weinheim); 1998 May; 331(5):163-9. PubMed ID: 9691247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tricyclic heteroaromatic systems. 2-Phenyl-1,2,4-triazolo[1,5-c][1,3]benzoxazin-5-one: a novel benzodiazepine receptor ligand.
    Catarzi D; Cecchi L; Colotta V; Filacchioni ; Martini C; Giusti L; Lucacchini A; Valle G
    Farmaco; 1994 Feb; 49(2):89-92. PubMed ID: 8003185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,2,3-Triazole[4,5-d]pyridazines--II. New derivatives tested on adenosine receptors.
    Biagi G; Giorgi I; Livi O; Scartoni V; Martini C; Tacchi P; Merlino S; Pasero M
    Farmaco; 1994 Mar; 49(3):175-81. PubMed ID: 8043168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 4-amino-6-(hetero)arylalkylamino-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent A(2A) adenosine receptor antagonists.
    Colotta V; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
    Bioorg Med Chem; 2003 Dec; 11(24):5509-18. PubMed ID: 14642595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Amino[1,2,4]triazolo[1,5-c]quinazolines and Derived Novel Heterocycles: Syntheses and Structure-Activity Relationships of Potent Adenosine Receptor Antagonists.
    Burbiel JC; Ghattas W; Küppers P; Köse M; Lacher S; Herzner AM; Kombu RS; Akkinepally RR; Hockemeyer J; Müller CE
    ChemMedChem; 2016 Oct; 11(20):2272-2286. PubMed ID: 27531666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.
    Sarges R; Howard HR; Browne RG; Lebel LA; Seymour PA; Koe BK
    J Med Chem; 1990 Aug; 33(8):2240-54. PubMed ID: 2374150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tricyclic heteroaromatic systems 1,2,4-triazolo[1,5-a]quinoxalines: synthesis and benzodiazepine receptor activity.
    Catarzi D; Cecchi L; Colotta V; Melani F; Filacchioni G; Martini C; Giusti L; Lucacchini A
    Farmaco; 1993 Aug; 48(8):1065-78. PubMed ID: 8216669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of 4-cycloalkylamino-1, 2, 4-triazolo[4, 3-a]quinoxalin-1- one derivatives as A1 and A3 adenosine receptor antagonists.
    Colotta V; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Lucacchini A; Colotta V
    Arch Pharm (Weinheim); 2004 Jan; 337(1):35-41. PubMed ID: 14760626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,2,3-triazole[4,5-d]pyridazines. III--Synthesis of new 4-amino derivatives and their affinity toward adenosine receptors.
    Biagi G; Giorgi I; Livi O; Scartoni V; Lucacchini A; Senatore G; Barili PL
    Farmaco; 1994 May; 49(5):357-62. PubMed ID: 8080619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on specific inhibition of benzodiazepine receptor binding by some C-benzoyl-1,2,3-triazole derivatives.
    Biagi G; Giorgi I; Livi O; Lucacchini A; Martini C; Scartoni V
    J Pharm Sci; 1993 Sep; 82(9):893-6. PubMed ID: 8229686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,2,4-Triazolo[5,1-i]purine derivatives as highly potent and selective human adenosine A(3) receptor ligands.
    Okamura T; Kurogi Y; Nishikawa H; Hashimoto K; Fujiwara H; Nagao Y
    J Med Chem; 2002 Aug; 45(17):3703-8. PubMed ID: 12166943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.